Literature DB >> 7689009

Abnormal mRNA splicing resulting from three different mutations in the CFTR gene.

J Hull1, S Shackleton, A Harris.   

Abstract

Three different putative splicing mutations in the CFTR gene have been studied by analysing mRNA extracted from nasal epithelial cells harvested from patients with cystic fibrosis. Six patients were analysed, all of whom had classical symptoms of cystic fibrosis (CF). Two patients carried the 621 + 1G-->T mutation, 3 patients carried the 1717 - 1G-->A mutation and 1 patient carried the 1898 + 1G-->A mutation. All patients carried the delta F508 mutation on the other chromosome. Ten non-CF control subjects were also studied. The 621 + 1G-->T mutation resulted in activation of an alternative splice site within exon 4 in one patient and activation of this site or skipping of exon 4 in the other patient. The 1717 - 1G-->A mutation resulted in skipping of exon 11 in all 3 patients studied and the 1898 + 1G-->T mutation resulted in skipping of exon 12. These experiments demonstrate that these mutations do result in aberrant splicing of CFTR mRNA as predicted from the changes in genomic sequence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689009     DOI: 10.1093/hmg/2.6.689

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.

Authors:  Molly B Sheridan; Timothy W Hefferon; Nulang Wang; Christian Merlo; Carlos Milla; Drucy Borowitz; Eric D Green; Peter J Mogayzel; Garry R Cutting
Journal:  J Med Genet       Date:  2010-11-20       Impact factor: 6.318

2.  Experimental assessment of splicing variants using expression minigenes and comparison with in silico predictions.

Authors:  Neeraj Sharma; Patrick R Sosnay; Anabela S Ramalho; Christopher Douville; Arianna Franca; Laura B Gottschalk; Jeenah Park; Melissa Lee; Briana Vecchio-Pagan; Karen S Raraigh; Margarida D Amaral; Rachel Karchin; Garry R Cutting
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

3.  Two CF patients, one homozygous for the 621 + 1G > T splice mutation, the other homozygous for the 1898 + 1G > A splice mutation.

Authors:  J P Cheadle; A L Meredith; L Millar-Jones; M C Goodchild
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

Review 4.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

5.  A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.

Authors:  K Will; T Dörk; M Stuhrmann; T Meitinger; R Bertele-Harms; B Tümmler; J Schmidtke
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Molecular analysis of four lactate dehydrogenase-A mutants in the mouse.

Authors:  R Sandulache; W Pretsch; B Chatterjee; W Gimbel; J Graw; J Favor
Journal:  Mamm Genome       Date:  1994-12       Impact factor: 2.957

7.  Skipping of multiple CFTR exons is not a result of single exon omissions.

Authors:  A Rickers; F Rininsland; L Osborne; J Reiss
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

8.  Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12.

Authors:  Ariful Haque; Emanuele Buratti; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2009-11-12       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.